Answers are grounded in this paper and cite their sources.
Stem cell therapy shows great potential for regenerative medicine but faces significant challenges in the post-radiotherapy tumor microenvironment, since there exit persistent DNA damage and reduced cell viability. Although pluripotent stem cells of human are largely used in stem cell therapies, the potential impact of their distinct pluripotency states, naïve (pre-implantation) and primed (post-implantation), on radiation response remains largely unexplored. This study proposes a comparative analysis of human primed and naïve pluripotent stem cells (hPSCs) to test differential resistance to ionizing radiation. The experimental design involves generating naïve and primed iPSCs through mRNA-based reprogramming from human dermal fibroblasts to ensure a consistent genetic background, followed by exposed to a gradient of γ-radiation doses. Cell viability will be measured quantitively using the CCK-8 assay, and the DNA double-strand break (DSB) repairing rate will be evaluated through long-amplicon quantitative PCR assay (QPCR) to calculate lesion frequency. I hypothesize that one pluripotent state will demonstrate superior damage response, shown through either a higher cell survival percentage or an accelerated DNA repair rate. Identifying which state possesses greater inherent resistance could provide critical evidence of selecting or engineering more resilient stem cells, thereby improving the efficiency and applicability of stem cell therapies following a radiotherapy.
No takes yet. Share an insight, caveat, or question.
Yuliang Ma (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: